viernes, 31 de diciembre de 2010

Manejo general y en medicina extrahospitalaria de...

Maximo Cuadros Chavez posted in cibermedicos.Maximo Cuadros Chavez2:55am Jan 1

Manejo general y en medicina extrahospitalaria de los síndromes alérgicos

Debido a la alta prevalencia de las enfermedades alérgicas, éstas constituyen una causa muy frecuente de consulta en los distintos niveles asistenciales. Es el médico de familia el que se plantea inicialmente la valoración de la sintomatología, las pruebas complementarias y el seguimiento, cuándo derivar al paciente al especialista y cómo modificar las dosis de los fármacos utilizados para el tratamiento de los distintos síndromes según su evolución. Estos aspectos del manejo general y extrahospitalario del paciente con enfermedad alérgica son los que vamos a comentar a continuación.

pulse sobre
http://www.facebook.com/l/eedafs4ga37sS1s17z1M7mqbIHw;www.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13137896&pident_usuario=0&pident_revista=62&fichero=62v10n34a13137896pdf001.pdf&ty=137&accion=L&origen=medicine&web=www.medicineonline.es&lan=es

Epinephrine and its use in anaphylaxis: current...


Maximo Cuadros Chavez posted in cibermedicos.Maximo Cuadros Chavez2:13am Jan 1

Epinephrine and its use in anaphylaxis: current issues
http://www.facebook.com/l/eedafyFnR0kDQy3SqNcIjXywKaQ;pt.wkhealth.com/pt/re/merck/pdfhandler.00130832-201008000-00016.pdf;jsessionid=NpMQm545K3v7m1qrJd2jfqssp93cnSHrn77JQT1mQvgnGXGC1vCS!1507367712!181195629!8091!-1

 

View Post on Facebook · Edit Email Settings · Reply to this email to add a comment.

antileukotriene therapy



 

Recent advances in antileukotriene therapy.

Pharmacotherapy and evidence based medicine

Current Opinion in Allergy & Clinical Immunology. 10(4):370-376, August 2010.
Scadding, Guy W a; Scadding, Glenis K b

Abstract:
Purpose of review: Despite profound effects of leukotrienes in experimental models, clinical responses to antileukotriene drugs are highly heterogeneous. This review discusses recent advances concerning the molecular mechanisms of antileukotrienes as well as their efficacy in various clinical scenarios and patient groups.

Recent findings: Appreciation of the role of leukotriene E4 and the existence of its distinct receptors may explain the limited efficacy of current leukotriene receptor antagonists. Pharmacogenetic studies highlight the influence of several leukotriene pathway genes on clinical responsiveness. Benefits of addition of antileukotrienes to inhaled corticosteroids in chronic adult asthmatics have been shown, but their role in acute asthma is unclear. Evidence suggests they are not a first-line treatment for allergic rhinitis or urticaria, but may provide useful additional therapy. In children antileukotrienes provide symptomatic benefit in preschool wheezers, but have no clear role in bronchiolitis or acute asthma. Adherence to montelukast appears superior to inhaled corticosteroids. Use in sleep-disordered breathing and eosinophilic gastroenteropathies warrants further investigation. Despite recent concerns thorough analysis of existing data suggests antileukotrienes are well tolerated drugs. The possible link with Churg-Strauss syndrome requires further investigation.

Summary: The leukotriene pathway remains an attractive target in asthma and allergic disease, particularly in light of renewed appreciation of the role of leukotriene E4. Clarification of the clinical role of antileukotrienes is needed.

(C) 2010 Lippincott Williams & Wilkins, Inc.


jueves, 30 de diciembre de 2010

Las plantas medicinales (primera parte)...

Maximo Cuadros Chavez posted in cibermedicos.Maximo Cuadros Chavez3:53pm Dec 30

Las plantas medicinales (primera parte)
http://www.facebook.com/l/0259cjJ8p5znJy0Zy4CiwKuy-kw;www.slan.org.ve/publicaciones/completas/plantas_medicinales_1.asp
Las plantas medicinales (segunda parte)
http://www.facebook.com/l/0259ck5sV1sKPdLmi-K2gQa_A1Q;www.slan.org.ve/publicaciones/completas/plantas_medicinales_2.asp


No son tan inofensivas como parecen

Dra. Nubilde Martínez
Farmaceuta. Especialista en toxicología clínica. Doctorado en Ciencias de la
Educación.Trabajo original en el Boletín de Nutrición Infantil CANIA. Año 4,
Nro. 8. noviembre de 2003

Atte.
Dr.Máximo Cuadros Chávez
Celular 99199698 – Movistar - rpm #800515

http://www.facebook.com/l/0259cv9h-uzY0b1Csl14Pz8mLEQ;es.groups.yahoo.com/group/interno_residente_medico_PERU/
http://www.facebook.com/l/0259cSggZGWW6pDlgh-g_WXOLbw;es.groups.yahoo.com/group/SANFERNANDOPERU/
http://es-la.facebook.com/people/Maximo-Cuadros-Chavez/100001101314342
http://www.facebook.com/group.php?gid=118221131544173
http://www.facebook.com/home.php?sk=group_150017968368005&ap=1
http://www.facebook.com/l/0259c5I3Qnpt56ryr66adrEmjQQ;medicalia.ning.com/
UNYK: 245 HRP

----------

Trastornos nutricionales

 
Trastornos nutricionales
 
Obesidad. Concepto. Clasificación. Implicaciones fisiopatológicas. Complicaciones asociadas. Valoración clínica
pulse sobre visualizar documento
Tratamiento de la obesidad. Medidas de estilo de vida y régimen alimentario. Tratamiento farmacológico. Tratamiento quirúrgico
pulse sobre visualizar documento
Desnutrición. Hipovitaminosis
pulse sobre visualizar documento
Estimación de requerimientos nutricionales. Nutrición en situaciones específicas
pulse sobre visualizar documento
Suplementos nutricionales. Clasificación. Indicaciones. Contraindicaciones. Valoración de la respuesta. Efectos secundarios
pulse sobre visualizar documento
Protocolo de valoración del estado nutricional
pulse sobre visualizar documento
Protocolo diagnóstico de la obesidad
pulse sobre visualizar documento
Protocolo terapéutico y de seguimiento de la obesidad
pulse sobre visualizar documento
Protocolo diagnóstico de la sospecha de astenia de origen endocrino
pulse sobre visualizar documento
Indicaciones y contraindicaciones de la nutrición enteral y parenteral
pulse sobre visualizar documento
Protocolo terapéutico de los estados de desnutrición

pulse sobre visualizar documento


Atte.Dr.Máximo Cuadros Chávez
Celular 99199698 – Movistar - rpm #800515

http://es.groups.yahoo.com/group/interno_residente_medico_PERU/
http://es.groups.yahoo.com/group/SANFERNANDOPERU/
http://es-la.facebook.com/people/Maximo-Cuadros-Chavez/100001101314342

http://www.facebook.com/group.php?gid=118221131544173
http://www.facebook.com/home.php?sk=group_150017968368005&ap=1
http://medicalia.ning.com/
UNYK: 245 HRP

martes, 28 de diciembre de 2010

A Meta-Analysis of the Efficacy and Tolerability of Interferon-􀁃 in Multiple Sclerosis, Overall and by Drug and Disease Type




Murillo Santucci Cesar de Assunção
Unidade de Terapia Intensiva adulto
Disciplina de Anestesiologia, Dor e Terapia Intensiva
Escola Paulista de Medicina
Rua Napoleão de Barros,715
Vila Clementino - São Paulo - CEP: 04024-002
Tel/Fax: +55-11-55757768
Tel/Fax: +55-11- 55764069











martes, 14 de diciembre de 2010

domingo, 12 de diciembre de 2010

intoxicación por humo


 

Bases del manejo clínico de la intoxicación por humo de incendios «Docohumo Madrid 2010»
pulse sobre visualizar documento
 


__._,_.___

Tratamiento de la fibromialgia

 

----- Mensaje reenviado ----
De: Victor Whizar-Lugo <vwhizar@anestesia-dolor.org>
Para: maximocuadros@yahoo.es
Enviado: dom,12 diciembre, 2010 08:07
Asunto: Tratamiento de la fibromialgia

 Anunciate con Anestesia-Dolor

Anestesia y Medicina del Dolor
Siguenos en:
Find us on Facebook Follow us on Twitter
Próximos Eventos
  
siguenos en facebook
Registrate con nosotros
Registrate a nuestra lista 
Conoce México
Ligas
 

No:343     

Diciembre 12, 2010
 Colores de Mexico

Estimad@ Maximo Jesus Cuadros Chavez:

Farmacoterapia de la fibromialgia: enfoque sobre duloxetina

Pharmacotherapy of  Fibromyalgia: Focus on Duloxetine
Eric Serra and Michel Andrejak
Amiens, France. Email: serra.eric@chu-amiens.fr
Clinical Medicine: Therapeutics 2009:1 1617-1627

 

Abstract
Context: Fibromyalgia syndrome (FMS) is a frequent medical condition characterized by chronic widespread pain and reduced pain threshold. Associated symptoms include fatigue, non restorative sleep, and psychological distress. As usual in medicine, even if the pathogenesis is unclear, some treatments are useful to help patients. Objectives: Tricyclic antidepressants were the first drugs used to treat FMS. More recently, among serotonin-norepinephrine reuptake inhibitors, duloxetine was approved by US Food and Drug Administration to treat FMS. Duloxetine is used for the management of major depressive disorder, neuropathic pain, generalized anxiety disorder, and stress incontinence. In the pharmacotherapy of  fibromyalgia, a focus is presented on the drug duloxetine. Results: Mechanism of action, metabolism and pharmacokinetic profile are presented. Clinical studies of Duloxetine showed an acceptable efficacy for this chronic condition: Number Need to Treat (NTT) of 4.7 to 9.9, through two 3-month placebo-controlled trials and two 6-month trials. Evaluation criteria are discussed. Safety of this medication has been found to be satisfactory, with nausea as the most common adverse event, in almost 20% of cases. Conclusion: Treatment algorithm for duloxetine is presented inside FMS treatment strategy. With duloxetine, it is important to start low and increase slowly to prevent or minimize adverse events: 30 mg/day up to 60 mg/day in the second week and if necessary up to 90-120 mg/day. It is possible to treat for 3 to 6 months, possibly up to 12 months. The drug could be decreased 2 to 4 weeks before stopping, with regular assessments during this time. International recommendations insist on multimodal treatments: drug and non drug. Also effective for anxiety and depression, duloxetine ranks among the first place drugs for FMS.
Keywords: duloxetine, fibromyalgia, pharmacotherapy.

 

Artí­culo en PDF 

 

Pregabalina y síndrome de fibromialgia: una opción terapéutica.

Pregabalin and Fibromyalgia Syndrome: A Treatment Option
Kim Lawson
Biomedical Research Centre, Sheffield Hallam University, City Campus, Sheffield, S1 1WB, UK. Email: k.lawson@shu.ac.uk
Clinical Medicine: Therapeutics 2009:1 809-824


Abstract: Fibromyalgia (FM) is a chronic complex pain disorder that is multidimensional and exhibits heterogeneity requiring a long-term multidisciplinary approach to management. Many of the drugs used in the treatment of FM have been focused to the management of single symptoms; often such drugs fail to demonstrate acceptable efficacy in the majority of the patient population. Pregabalin is an α2-δ ligand that regulates the release and postsynaptic actions of  neurotransmitters related to analgesic, anticonvulsant and anxiolytic properties. In randomized, double-blind, placebo-controlled studies, pregabalin has demonstrated an improvement in
pain, sleep and fatigue symptoms associated with FM, as well as offering an improvement in parameters related to quality of life. Although the positive outcomes obtained with pregabalin support its use as an option for the management of FM, the efficacy was restricted to a selected patient population outside of the usual care setting. Current data do not allow an explanation where there are any limitations of pregabalin as a treatment of patients with FM, as to whether this is a deficiency of the drug or the process of assessment (e.g. assessment tools of FM, clinical trial design).
Keywords: fibromyalgia, pregabalin, treatment, pain, fatigue, sleep

 

Artí­culo en PDF 

Atentamente
Anestesiología y Medicina del Dolor

martes, 7 de diciembre de 2010

Vestibular migraña

Se puede conseguir ???

Vestibular migraine.

Strupp M, Versino M, Brandt T.

Handb Clin Neurol. 2010;97:755-71.
GraciasAL

Enviado desde mi iPhone

El 07/12/2010, a las 12:56, Vicente Rey <vicente.rey@gmail.com> escribió:

2, 3, 4 = sent

2010/12/7 s a <doc.shipsaiims@gmail.com>
hi does anybody have access to any of these articles; i need them
urgently for an interview; thanking you in anticipation; i shall b v v
v v gr8ful!!!!

1.      Nayak A, Iyer VK, Agarwal S, Agarwala S. Fine Needle Aspiration
Cytology of Fetal Rhabdomyomatous and Teratoid Wilms Tumor. Acta Cytol
(Accepted for publication).

2.      Jha P, Agarwal S, Pathak P, Srivastava A, Suri V, Sharma MC,
Chosdol K, Srivastava T, Gupta D, Gupta A, Suri A, Sarkar C.
Heterozygosity status of 1p and 19q and its correlation with p53
protein expression and EGFR amplification in patients with astrocytic
tumors: novel series from India. Cancer Genet Cytogenet.
2010;198(2):126-34.
3.       Agarwal S, Gupta R, Iyer VK, Mathur SR, Ray R. Cytopathological
diagnosis of alveolar soft part sarcoma, a rare soft tissue neoplasm.
Cytopathology. 2010 Aug 22.
4.      Agarwal S, Iyer VK, Agarwala S, Mathur SR, Aron M, Gupta SD, Verma
K. Apoptotic protein expression in favorable histology Wilms tumor
correlates with tumor recurrence. Pediatric Surgery International.
2010 Sep.


--
Dr Shipra Agarwal
M.D. (Pathology)
Senior resident
Department of Pathology
All India Institute of Medical Sciences
New Delhi

--
welcome to http://www.myescience.com   a good password forum, and medcine forum,  we provider special resoucres (some passwords)  for donators who donate >100 usd,  open http://www.myescience.com

  you can use paypal to donate, click the orange donate of index, or you can donate will western union (for member's group higher than Sophomores ),
For more options, visit this group at
http://groups.google.com/group/medical-passwords?hl=en

--
welcome to http://www.myescience.com a good password forum, and medcine forum, we provider special resoucres (some passwords) for donators who donate >100 usd, open http://www.myescience.com

you can use paypal to donate, click the orange donate of index, or you can donate will western union (for member's group higher than Sophomores ),
For more options, visit this group at
http://groups.google.com/group/medical-passwords?hl=en

--
welcome to http://www.myescience.com a good password forum, and medcine forum, we provider special resoucres (some passwords) for donators who donate >100 usd, open http://www.myescience.com

you can use paypal to donate, click the orange donate of index, or you can donate will western union (for member's group higher than Sophomores ),
For more options, visit this group at
http://groups.google.com/group/medical-passwords?hl=en

Anticoagulación oral...